Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Irf2bplem1/Cya
Common Name:
Irf2bpl-KO
Product ID:
S-KO-06968
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Irf2bpl-KO
Strain ID
KOCMP-238330-Irf2bpl-B6J-VA
Gene Name
Irf2bpl
Product ID
S-KO-06968
Gene Alias
6430527G18Rik; Eap1
Background
C57BL/6JCya
NCBI ID
238330
Modification
Conventional knockout
Chromosome
12
Phenotype
MGI:2442463
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Irf2bplem1/Cya mice (Catalog S-KO-06968) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000038422
NCBI RefSeq
NM_145836
Target Region
Exon 1
Size of Effective Region
~4.1 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Irf2bpl, or Interferon regulatory factor 2 binding protein-like, encodes a member of the IRF2BP family of transcriptional regulators. Its exact biological function remains somewhat obscure, but research indicates its importance in the nervous system [1,2,3,4,5,6,7,8,9]. Bioinformatics signatures suggest it is intolerant to variation, hinting at its crucial role in biological processes. Genetic models, such as the fruit-fly ortholog pits, have been valuable in studying its function [1].

In humans, damaging heterozygous variants in Irf2bpl are associated with a range of neurological phenotypes. Nonsense variants often lead to severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and lack of coordination, while missense variants may result in global developmental delay and seizures with a relatively milder phenotype [1]. In fruit-flies, complete loss of pits is lethal early in development, and partial knockdown in neurons causes neurodegeneration, highlighting its requirement for proper neuronal function and maintenance [1]. Moreover, in Drosophila, overexpression of either Irf2bpl or Pits represses Wnt transcription, and neuronal depletion of Pits leads to increased wingless (wg) levels in the brain, axonal loss, which can be mitigated by inhibiting Wg signaling. Loss of irf2bpl in zebrafish also causes neurological defects with increased wnt1 transcription [7].

In conclusion, Irf2bpl is essential for proper neuronal function and maintenance, as revealed through model-based research. Variants in this gene are associated with various neurological disorders, including developmental and epileptic encephalopathy, progressive myoclonus epilepsy, and late-onset ataxia. Studies using model organisms like flies and zebrafish have provided valuable insights into the role of Irf2bpl in the nervous system and the underlying mechanisms of these neurological diseases [1,3,5,6,7].

References:

1. Marcogliese, Paul C, Shashi, Vandana, Spillmann, Rebecca C, Bellen, Hugo J, Pena, Loren D M. 2018. IRF2BPL Is Associated with Neurological Phenotypes. In American journal of human genetics, 103, 245-260. doi:10.1016/j.ajhg.2018.07.006. https://pubmed.ncbi.nlm.nih.gov/30057031/

2. Shelkowitz, Emily, Singh, Jasleen K, Larson, Austin, Elias, Ellen R. 2019. IRF2BPL gene mutation: Expanding on neurologic phenotypes. In American journal of medical genetics. Part A, 179, 2263-2271. doi:10.1002/ajmg.a.61328. https://pubmed.ncbi.nlm.nih.gov/31432588/

3. Heide, Solveig, Davoine, Claire-Sophie, Cunha, Paulina, Brice, Alexis, Durr, Alexandra. 2023. IRF2BPL Causes Mild Intellectual Disability Followed by Late-Onset Ataxia. In Neurology. Genetics, 9, e200096. doi:10.1212/NXG.0000000000200096. https://pubmed.ncbi.nlm.nih.gov/38235039/

4. Sinha Ray, Shrestha, Dutta, Debdeep, Dennys, Cassandra, Marcogliese, Paul C, Meyer, Kathrin C. . Mechanisms of IRF2BPL-related disorders and identification of a potential therapeutic strategy. In Cell reports, 41, 111751. doi:10.1016/j.celrep.2022.111751. https://pubmed.ncbi.nlm.nih.gov/36476864/

5. Costa, Cinzia, Oliver, Karen L, Calvello, Carmen, Berkovic, Samuel F, Prontera, Paolo. 2023. IRF2BPL: A new genotype for progressive myoclonus epilepsies. In Epilepsia, 64, e164-e169. doi:10.1111/epi.17557. https://pubmed.ncbi.nlm.nih.gov/36810721/

6. Gardella, Elena, Michelucci, Roberto, Christensen, Hanne M, Møller, Rikke S, Rubboli, Guido. 2023. IRF2BPL as a novel causative gene for progressive myoclonus epilepsy. In Epilepsia, 64, e170-e176. doi:10.1111/epi.17634. https://pubmed.ncbi.nlm.nih.gov/37114479/

7. Marcogliese, Paul C, Dutta, Debdeep, Ray, Shrestha Sinha, Yeo, Nan Cher, Bellen, Hugo J. 2022. Loss of IRF2BPL impairs neuronal maintenance through excess Wnt signaling. In Science advances, 8, eabl5613. doi:10.1126/sciadv.abl5613. https://pubmed.ncbi.nlm.nih.gov/35044823/

8. Yang, Fei, Li, Hui, Dai, Yi, Zhang, Ran, Zhang, Jiang-Tao. 2023. IRF2BPL gene variants with dystonia: one new Chinese case report. In BMC neurology, 23, 32. doi:10.1186/s12883-023-03077-x. https://pubmed.ncbi.nlm.nih.gov/36670390/

9. Bauersachs, Daniel, Bomholtz, Louise, Del Rey Mateos, Sara, Kühn, Ralf, Lisowski, Pawel. 2024. Novel human neurodevelopmental and neurodegenerative disease associated with IRF2BPL gene variants-mechanisms and therapeutic avenues. In Frontiers in neuroscience, 18, 1426177. doi:10.3389/fnins.2024.1426177. https://pubmed.ncbi.nlm.nih.gov/38903604/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest